108 related articles for article (PubMed ID: 19435207)
1. [The effects of Celebrex on mammary tumorigenesis and aging in HER2/neu transgenic mice].
Piskunova TS; Suspitsin EN; Sokolenko AP; Zabezhinskiĭ MA; Imianitov EI; Semenchenko AV; Anisimov VN
Vopr Onkol; 2009; 55(1):89-92. PubMed ID: 19435207
[TBL] [Abstract][Full Text] [Related]
2. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.
Lanza-Jacoby S; Miller S; Flynn J; Gallatig K; Daskalakis C; Masferrer JL; Zweifel BS; Sembhi H; Russo IH
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1486-91. PubMed ID: 14693742
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.
Howe LR; Subbaramaiah K; Patel J; Masferrer JL; Deora A; Hudis C; Thaler HT; Muller WJ; Du B; Brown AM; Dannenberg AJ
Cancer Res; 2002 Oct; 62(19):5405-7. PubMed ID: 12359744
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model.
Tran-Thanh D; Buttars S; Wen Y; Wilson C; Done SJ
Cancer Prev Res (Phila); 2010 Feb; 3(2):202-11. PubMed ID: 20103725
[TBL] [Abstract][Full Text] [Related]
5. COX-2 inhibitors and genetic background reduce mammary tumorigenesis in cyclooxygenase-2 transgenic mice.
Narko K; Zweifel B; Trifan O; Ristimäki A; Lane TF; Hla T
Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):86-94. PubMed ID: 15967164
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Berstein LM; Egormin PA; Piskunova TS; Popovich IG; Zabezhinski MA; Kovalenko IG; Poroshina TE; Semenchenko AV; Provinciali M; Re F; Franceschi C
Exp Gerontol; 2005; 40(8-9):685-93. PubMed ID: 16125352
[TBL] [Abstract][Full Text] [Related]
7. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC; Springs AE; Chen WY
Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib: a novel treatment for lung cancer.
Abou-Issa H; Alshafie G
Expert Rev Anticancer Ther; 2004 Oct; 4(5):725-34. PubMed ID: 15485309
[TBL] [Abstract][Full Text] [Related]
9. COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer.
Yoshinaka R; Shibata MA; Morimoto J; Tanigawa N; Otsuki Y
Anticancer Res; 2006; 26(6B):4245-54. PubMed ID: 17201140
[TBL] [Abstract][Full Text] [Related]
10. The resistance to the tumor suppressive effects of COX inhibitors and COX-2 gene disruption in TRAMP mice is associated with the loss of COX expression in prostate tissue.
Wang X; Colby JK; Yang P; Fischer SM; Newman RA; Klein RD
Carcinogenesis; 2008 Jan; 29(1):120-8. PubMed ID: 17942462
[TBL] [Abstract][Full Text] [Related]
11. [Effect of light deprivation on homeostasis, life span and development of spontaneous tumors in HER-2/neu transgenic mice].
Baturin DA; Alimova IN; Popovich IG; Zabezhinskiĭ MA; Semenchenko AV; Iashin AI; Anisimov VN
Vopr Onkol; 2004; 50(3):332-8. PubMed ID: 15318708
[TBL] [Abstract][Full Text] [Related]
12. Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen.
Popovich IG; Zabezhinski MA; Egormin PA; Tyndyk ML; Anikin IV; Spasov AA; Semenchenko AV; Yashin AI; Anisimov VN
Int J Biochem Cell Biol; 2005 May; 37(5):1117-29. PubMed ID: 15743682
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective vs. nonselective cyclooxygenase inhibition on dynamic renal potassium excretion: a randomized trial.
Preston RA; Afshartous D; Alonso AB
Clin Pharmacol Ther; 2008 Aug; 84(2):208-11. PubMed ID: 18288080
[No Abstract] [Full Text] [Related]
14. Body weight is not always a good predictor of longevity in mice.
Anisimov VN; Arbeev KG; Popovich IG; Zabezhinksi MA; Rosenfeld SV; Piskunova TS; Arbeeva LS; Semenchenko AV; Yashin AI
Exp Gerontol; 2004 Mar; 39(3):305-19. PubMed ID: 15036390
[TBL] [Abstract][Full Text] [Related]
15. Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion.
Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S
Pharmazie; 2009 Apr; 64(4):258-9. PubMed ID: 19435145
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing effects of specific COX-2 inhibitor NSAIDs on growth and differentiation of mouse osteoblasts on titanium surfaces.
Arpornmaeklong P; Akarawatcharangura B; Pripatnanont P
Int J Oral Maxillofac Implants; 2008; 23(6):1071-81. PubMed ID: 19216276
[TBL] [Abstract][Full Text] [Related]
17. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2.
Davis VL; Jayo MJ; Ho A; Kotlarczyk MP; Hardy ML; Foster WG; Hughes CL
Cancer Res; 2008 Oct; 68(20):8377-83. PubMed ID: 18922910
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
19. Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth.
Bozzo F; Bassignana A; Lazzarato L; Boschi D; Gasco A; Bocca C; Miglietta A
Chem Biol Interact; 2009 Dec; 182(2-3):183-90. PubMed ID: 19682443
[TBL] [Abstract][Full Text] [Related]
20. Effect of celecoxib on anticonvulsant activity of carbamazepine against maximal electroshock-induced convulsions in mice.
Tayal V; Kalra BS; Chawla S
Methods Find Exp Clin Pharmacol; 2008 Dec; 30(10):727-30. PubMed ID: 19271020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
